Allogeneic haematopoietic stem cell transplantation (allo-HSCT) is considered to be the
strongest curative immunotherapy for various malignancies (primarily, but not limited to …

Haematopoietic stem cell transplantation (HSCT) is central to the management of many
haematological disorders. A frequent complication of HSCT is acute graft-versus-host …

Abstract In 2009, the American Society of Parenteral and Enteral Nutrition and its European
counterpart (Euopean Society for Parenteral and Enteral Nutrition) published guidelines …

Background Graft-versus-host-disease (GVHD) after liver transplantation (LT) is a deadly
complication with very limited data on risk factors, diagnosis and management. We report a …

Allogeneic hematopoietic stem cell transplantation (HSCT) has become an established
treatment modality for various hematological diseases. However, in allogeneic HSCT …

BACKGROUND In patients with head and neck and esophageal tumors, nutritional status
may deteriorate during concurrent chemoradiotherapy (CRT). The aim of this study was to …

Hematopoietic stem cell transplantation (HSCT) is a potentially life-saving therapy that often
comes at the cost of complications such as graft-versus-host disease and post-transplant …

Allogeneic hematopoietic stem cell transplantation (allo-SCT) offers cure for a variety of
conditions, in particular, but not limited to, hematologic malignancies. However, it can be …

Background Allogeneic hematopoietic stem cell transplantation (alloHSCT) is frequently
associated with impaired oral intake and malnutrition, which potentially increases morbidity …

Vitamin D was discovered 100 years ago and since then multiple studies have consistently
proved its effect on bone health and mineral metabolism. Further research has also explored …